Skip to content

RANDOMISED CONTROLLED TRIAL ON TRANSVERSE GROIN INCISION VS VERTICAL GROIN INCISION FOR EXPOSURE OF FEMORAL ARTERY IN PERIPHERAL ARTERIAL DISEASE

COMPARISON OF TRANSVERSE GROIN INCISION VS VERTICAL GROIN INCISION FOR EXPOSURE OF FEMORAL ARTERY IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE - A RANDOMISED CONTROL TRIAL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033952
Enrollment
80
Registered
2021-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: TRANSVERSE GROIN INCISION: Transverse incision parallel to inguinal crease is made for exposure of femoral artery for doing by-pass. Control Intervention1: VERTICAL GROIN INCISION: Vert

Sponsors

PGIMER Department of General Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing Femoral artery exposure for suprainguinal or infrainguinal by-pass in Chronic Limb Threatening Ischemia patients

Exclusion criteria

Exclusion criteria: - Patients where Redo exposure is required. - Patients who expired following procedure.

Design outcomes

Primary

MeasureTime frame
Surgical Site infection as per Szilagyi classificationTimepoint: At day 1, at day 4, at day 7, at day 28, at day 90

Secondary

MeasureTime frame
AmputationTimepoint: At day 1, at day 4, at day 7, at day 28, at day 90;Early infection of GraftTimepoint: At day 1, at day 4, at day 7, at day 28, at day 90;Lymphatic collectionTimepoint: At day 1,at day 4, at day 7,at day 28, at day 90;LymphorrheaTimepoint: At day 1, at day 4, at day 7,at day 28, at day 90;ParesthesiaTimepoint: At day 1, at day 4, at day 7, at day 28, at day 90

Countries

India

Contacts

Public ContactDr Renukaradhya Hiremath

PGIMER Chandigarh

Drajaysavlania@gmail.com9988130747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026